A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access

Dialysis vascular access thrombosis poses a substantial challenge for individuals undergoing hemodialysis. The efficacy and safety of apixaban, a direct oral coagulation factor Xa inhibitor, in preventing recurrent access thrombosis have yet to be explored. Here, a multicenter randomized control stu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney international 2024-11
Hauptverfasser:	Ko, Tsung-Yu, Wu, Chih-Cheng, Hsieh, Mu-Yang, Yang, Chung-Wei, Cheng, Chi-Hung, Chen, Chun-Kai, Kao, Hsien-Li
Format:	Artikel
Sprache:	eng
Schlagworte:	anticoagulation, apixaban, hemodialysis, thrombectomy, thrombosis, vascular access
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!